Novo Nordisk, a Danish private company, is the world's leading producer of enzymes and diabetes care products. It seeks to position itself as an environmentally responsive biotechnology company. The company focuses on environmentally friendly technologies, social equity, environmental justice and good business ethics. It hopes to achieve the role as forerunner through a corporate strategy of dialogue with non-governmental organizations (NGOs). How prepared is Novo Nordisk to adapt and sacrifice its commercial interests for environmental goals?.